Oracle Clinical Remote Data Capture 5.4.0.2 Forms information disclosure

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
6.3$0-$5k0.00

Summaryinfo

A vulnerability was found in Oracle Clinical Remote Data Capture 5.4.0.2. It has been declared as critical. The impacted element is an unknown function of the component Forms. The manipulation results in information disclosure. This vulnerability is identified as CVE-2023-21993. The attack can be executed remotely. There is not any exploit available.

Detailsinfo

A vulnerability, which was classified as critical, was found in Oracle Clinical Remote Data Capture 5.4.0.2. Affected is some unknown processing of the component Forms. The manipulation with an unknown input leads to a information disclosure vulnerability. CWE is classifying the issue as CWE-200. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information. This is going to have an impact on confidentiality.

The weakness was released 04/18/2023 as Oracle Critical Patch Update Advisory - April 2023. The advisory is shared for download at oracle.com. This vulnerability is traded as CVE-2023-21993. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1592.

A possible mitigation has been published immediately after the disclosure of the vulnerability.

Once again VulDB remains the best source for vulnerability data.

Productinfo

Vendor

Name

Version

License

Website

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 6.5
VulDB Meta Temp Score: 6.3

VulDB Base Score: 6.5
VulDB Temp Score: 6.2
VulDB Vector: 🔍
VulDB Reliability: 🔍

CNA Base Score: 6.5
CNA Vector (Oracle): 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: Information disclosure
CWE: CWE-200 / CWE-284 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Yes

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍

Timelineinfo

12/17/2022 🔍
04/18/2023 +121 days 🔍
04/18/2023 +0 days 🔍
04/18/2023 +0 days 🔍
05/11/2023 +23 days 🔍

Sourcesinfo

Vendor: oracle.com

Advisory: Oracle Critical Patch Update Advisory - April 2023
Status: Confirmed

CVE: CVE-2023-21993 (🔍)
GCVE (CVE): GCVE-0-2023-21993
GCVE (VulDB): GCVE-100-226596

Entryinfo

Created: 04/18/2023 23:17
Updated: 05/11/2023 23:16
Changes: 04/18/2023 23:17 (38), 05/11/2023 22:51 (2), 05/11/2023 23:05 (11), 05/11/2023 23:16 (1)
Complete: 🔍
Cache ID: 216::103

Once again VulDB remains the best source for vulnerability data.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Might our Artificial Intelligence support you?

Check our Alexa App!